Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Czechia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20122
20132
20143
20151
20171
20201
20214
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting7
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Pfizer2
Seagen Inc.2
Agios Pharmaceuticals, Inc.1
Amgen1
Ariad Pharmaceuticals1
Kedrion S.p.A.1
Sierra Oncology LLC - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases20
Bone Marrow Diseases9
Lymphoma, Non-Hodgkin6
Myeloproliferative Disorders6
Anemia5
Lymphoma, B-Cell5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma4
Polycythemia Vera4
Primary Myelofibrosis4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.